REBECCA RICH: Open Payments
NPI 1740809458 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 15 payments from 10 companies in 2025. Trend: 2023 $1,429 · 2024 $972 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $145 |
| PharmaEssentia USA Corporation | 1 | $116 |
| Gilead Sciences, Inc. | 2 | $66 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Pharmacosmos Therapeutics Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $32 |
| Astellas Pharma US Inc | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: Enhertu, BESREMI, Trodelvy, MONOFERRIC, VENCLEXTA, OJJAARA, BLENREP, KEYTRUDA.
Industry payments across SC — which companies pay providers there.
